The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127736241 12773624 1 I 201606 20160919 20160923 20160923 EXP US-ROCHE-1832772 ROCHE 66.07 YR M Y 0.00000 20160923 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127736241 12773624 1 PS RITUXAN RITUXIMAB 1 Intravenous (not otherwise specified) DOSE WAS BASED ON WEIGHT Y 103705 SOLUTION FOR INFUSION TIW
127736241 12773624 2 SS RITUXAN RITUXIMAB 1 Y 103705
127736241 12773624 3 SS NEULASTA PEGFILGRASTIM 1 Unknown LONGER DURATION GRANULATION STIMULATING MEDICATION D 125031
127736241 12773624 4 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Unknown Y 0
127736241 12773624 5 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Y 0
127736241 12773624 6 SS DOXORUBICIN DOXORUBICIN 1 Unknown Y 0
127736241 12773624 7 SS DOXORUBICIN DOXORUBICIN 1 Y 0
127736241 12773624 8 SS VINCRISTINE VINCRISTINE 1 Unknown Y 0
127736241 12773624 9 SS VINCRISTINE VINCRISTINE 1 Y 0
127736241 12773624 10 SS PREDNISOLONE. PREDNISOLONE 1 Unknown Y 0
127736241 12773624 11 SS PREDNISOLONE. PREDNISOLONE 1 Y 0
127736241 12773624 12 C CLARITIN (UNITED STATES) 2 Unknown 0 10 MG QD
127736241 12773624 13 C CLARITIN (UNITED STATES) 2 0
127736241 12773624 14 C FLONASE (UNITED STATES) 2 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127736241 12773624 1 Lymphoma
127736241 12773624 2 Non-Hodgkin's lymphoma
127736241 12773624 3 Neutropenia
127736241 12773624 4 Lymphoma
127736241 12773624 5 Non-Hodgkin's lymphoma
127736241 12773624 6 Lymphoma
127736241 12773624 7 Non-Hodgkin's lymphoma
127736241 12773624 8 Lymphoma
127736241 12773624 9 Non-Hodgkin's lymphoma
127736241 12773624 10 Lymphoma
127736241 12773624 11 Non-Hodgkin's lymphoma
127736241 12773624 12 Bone pain
127736241 12773624 13 Seasonal allergy
127736241 12773624 14 Seasonal allergy

Outcome of event

Event ID CASEID OUTC COD
127736241 12773624 OT
127736241 12773624 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
127736241 12773624 Asthenia
127736241 12773624 Bone pain
127736241 12773624 Decreased appetite
127736241 12773624 Drug ineffective
127736241 12773624 Fatigue
127736241 12773624 Neutropenia
127736241 12773624 Oropharyngeal pain
127736241 12773624 White blood cell count decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127736241 12773624 1 201603 20160714 0
127736241 12773624 4 201603 0
127736241 12773624 6 201603 0
127736241 12773624 8 201603 0
127736241 12773624 10 201603 0